These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 15700306)
1. Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice. Kabbarah O; Sotelo AK; Mallon MA; Winkeler EL; Fan MY; Pfeifer JD; Shibata D; Gutmann DH; Goodfellow PJ Int J Cancer; 2005 Jul; 115(4):666-9. PubMed ID: 15700306 [TBL] [Abstract][Full Text] [Related]
2. A panel of repeat markers for detection of microsatellite instability in murine tumors. Kabbarah O; Mallon MA; Pfeifer JD; Edelmann W; Kucherlapati R; Goodfellow PJ Mol Carcinog; 2003 Dec; 38(4):155-9. PubMed ID: 14639654 [TBL] [Abstract][Full Text] [Related]
3. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433 [TBL] [Abstract][Full Text] [Related]
4. Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Smith-Roe SL; Hegan DC; Glazer PM; Buermeyer AB Mutat Res; 2006 Feb; 594(1-2):101-12. PubMed ID: 16256150 [TBL] [Abstract][Full Text] [Related]
5. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552 [TBL] [Abstract][Full Text] [Related]
6. Hypermutation in Ig V genes from mice deficient in the MLH1 mismatch repair protein. Phung QH; Winter DB; Alrefai R; Gearhart PJ J Immunol; 1999 Mar; 162(6):3121-4. PubMed ID: 10092760 [TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Wang H; Douglas W; Lia M; Edelmann W; Kucherlapati R; Podsypanina K; Parsons R; Ellenson LH Am J Pathol; 2002 Apr; 160(4):1481-6. PubMed ID: 11943731 [TBL] [Abstract][Full Text] [Related]
8. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency. Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362 [TBL] [Abstract][Full Text] [Related]
11. Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice. Kakinuma S; Kodama Y; Amasaki Y; Yi S; Tokairin Y; Arai M; Nishimura M; Monobe M; Kojima S; Shimada Y Oncogene; 2007 May; 26(20):2945-9. PubMed ID: 17086208 [TBL] [Abstract][Full Text] [Related]
12. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
13. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034 [TBL] [Abstract][Full Text] [Related]
14. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465 [TBL] [Abstract][Full Text] [Related]
15. Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomas. Reiss C; Haneke T; Völker HU; Spahn M; Rosenwald A; Edelmann W; Kneitz B Leuk Lymphoma; 2010 Oct; 51(10):1875-86. PubMed ID: 20858091 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
17. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551 [TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Edelmann W; Yang K; Kuraguchi M; Heyer J; Lia M; Kneitz B; Fan K; Brown AM; Lipkin M; Kucherlapati R Cancer Res; 1999 Mar; 59(6):1301-7. PubMed ID: 10096563 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]